SIC 3841 – Surgical and Medical Instruments and Apparatus
| Valuation | |
|---|---|
| Market Cap ($M) | 29.72 |
| Enterprise Value ($M) | 30.88 |
| Book Value ($M) | 72.02 |
| Book Value / Share | 1.73 |
| Price / Book | 0.41 |
| NCAV ($M) | -6.34 |
| NCAV / Share | -0.15 |
| Price / NCAV | -4.69 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.42 |
| Return on Assets (ROA) | -0.31 |
| Return on Equity (ROE) | -0.55 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.15 |
| Current Ratio | 2.44 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 40.53 |
| Assets | 118.88 |
| Liabilities | 46.87 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 27.04 |
| Operating Income | -57.02 |
| Net Income | -42.75 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -38.56 |
| Cash from Investing | -8.93 |
| Cash from Financing | 38.53 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Nantahala Capital Partners Limited Partnership | 5.78 | ||
| 13G/A | Nantahala Capital Management, LLC | 9.99 | ||
| 13G/A | Solid Financial LLC | 4.60 | 13.14 | |
| 13G/A | Titan Trust 2024 I | 9.99 | ||
| 13G | Tasso Partners, LLC | 8.82 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 16,986 | 106,766 | 15.91 | |
| 17,333 | 42,629 | 40.66 | |
| 33,305 | 105,891 | 31.45 | |
| 31,465 | 169,835 | 18.53 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CODX – Co-Diagnostics, Inc. | CTSO – Cytosorbents Corporation |
| DCTH – Delcath Systems, Inc. | ECOR – electroCore, Inc. |
| ESTA – Establishment Labs Holdings Inc. |
Financial data and stock pages provided by
Fintel.io